In summary, this study demonstrates that the molecular mechanism of celastrol in the treatment of B16-F10 melanoma cells involves the inhibition of HIF-1α mRNA expression by regulating the PI3K/AKT/mTOR signaling pathway. The gene discussed is MTOR; the disease is melanoma.